D.A. Davidson & CO. Has $1.13 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS)

D.A. Davidson & CO. raised its holdings in Doximity, Inc. (NASDAQ:DOCS) by 15.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,209 shares of the company’s stock after purchasing an additional 2,786 shares during the quarter. D.A. Davidson & CO.’s holdings in Doximity were worth $1,132,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Shaker Investments LLC OH acquired a new stake in Doximity in the fourth quarter valued at about $559,000. Fountainhead AM LLC bought a new position in shares of Doximity in the third quarter worth about $710,000. Penserra Capital Management LLC acquired a new stake in shares of Doximity in the 3rd quarter valued at approximately $2,384,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Doximity during the 4th quarter valued at approximately $362,000. Finally, Stratos Wealth Partners LTD. acquired a new position in Doximity during the 4th quarter worth approximately $203,000. Institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

Shares of NASDAQ:DOCS opened at $72.25 on Monday. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The business’s 50-day moving average is $60.19 and its 200-day moving average is $49.38. The company has a market capitalization of $13.49 billion, a price-to-earnings ratio of 72.25, a P/E/G ratio of 4.10 and a beta of 1.39.

Wall Street Analysts Forecast Growth

DOCS has been the subject of several research analyst reports. Wells Fargo & Company reiterated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. KeyCorp lowered their target price on Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $31.00 to $78.00 in a research note on Friday, February 7th. The Goldman Sachs Group boosted their price target on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Finally, Stephens started coverage on shares of Doximity in a report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective for the company. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and an average target price of $64.22.

Insider Buying and Selling at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 37.40% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.